DE69737691D1 - Impfstoff, der peroxiredoxin enthält - Google Patents
Impfstoff, der peroxiredoxin enthältInfo
- Publication number
- DE69737691D1 DE69737691D1 DE69737691T DE69737691T DE69737691D1 DE 69737691 D1 DE69737691 D1 DE 69737691D1 DE 69737691 T DE69737691 T DE 69737691T DE 69737691 T DE69737691 T DE 69737691T DE 69737691 D1 DE69737691 D1 DE 69737691D1
- Authority
- DE
- Germany
- Prior art keywords
- acid sequences
- oxin
- vaccine containing
- containing peroxide
- peroxiredoxin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 229960005486 vaccine Drugs 0.000 title abstract 2
- 150000002978 peroxides Chemical class 0.000 title 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 title 1
- 102000007456 Peroxiredoxin Human genes 0.000 abstract 2
- 102000004243 Tubulin Human genes 0.000 abstract 2
- 108090000704 Tubulin Proteins 0.000 abstract 2
- 208000036815 beta tubulin Diseases 0.000 abstract 2
- 150000007523 nucleic acids Chemical group 0.000 abstract 2
- 108030002458 peroxiredoxin Proteins 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 241000577452 Dicrocoelium Species 0.000 abstract 1
- 206010061217 Infestation Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 241000242541 Trematoda Species 0.000 abstract 1
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 1
- 230000000890 antigenic effect Effects 0.000 abstract 1
- 244000000013 helminth Species 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003071 parasitic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43536—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
- C07K14/43559—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from trematodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9612214.8A GB9612214D0 (en) | 1996-06-11 | 1996-06-11 | Vaccine |
| GB9612214 | 1996-06-11 | ||
| PCT/GB1997/001573 WO1997047740A2 (en) | 1996-06-11 | 1997-06-11 | VACCINE CONTAINING A PEROXIREDOXIN AND/OR A β-TUBULIN |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69737691D1 true DE69737691D1 (de) | 2007-06-14 |
| DE69737691T2 DE69737691T2 (de) | 2008-01-10 |
Family
ID=10795122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69737691T Expired - Fee Related DE69737691T2 (de) | 1996-06-11 | 1997-06-11 | Impfstoff, der peroxiredoxin enthält |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6676944B2 (de) |
| EP (1) | EP0953047B1 (de) |
| CN (1) | CN1221451A (de) |
| AT (1) | ATE361363T1 (de) |
| AU (1) | AU732807B2 (de) |
| BR (1) | BR9710849A (de) |
| CA (1) | CA2256710A1 (de) |
| DE (1) | DE69737691T2 (de) |
| ES (1) | ES2287954T3 (de) |
| GB (1) | GB9612214D0 (de) |
| NZ (1) | NZ333265A (de) |
| WO (1) | WO1997047740A2 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006505290A (ja) * | 2002-11-10 | 2006-02-16 | インスティテュート オブ セル バイオフィジクス ロシアン アカデミー オブ サイエンシーズ | 抗酸化医薬化合物、ポリペプチドの産生方法、治療方法 |
| US7265248B1 (en) | 2005-04-29 | 2007-09-04 | Technology Innovations, Llc | Compositions and methods for the treatment of malaria |
| US8572330B2 (en) * | 2005-12-19 | 2013-10-29 | Commvault Systems, Inc. | Systems and methods for granular resource management in a storage network |
| CN101294154B (zh) * | 2007-04-25 | 2012-05-02 | 中国农业科学院上海兽医研究所 | 一种生产大片吸虫组织蛋白酶l1的方法 |
| WO2011043962A2 (en) | 2009-10-07 | 2011-04-14 | Wyeth Llc | Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof |
| WO2011071992A1 (en) * | 2009-12-08 | 2011-06-16 | Health Research, Inc. | Inhibition of tumor angiogenesis by inhibition of peroxiredoxin 1 (prx1) |
| IN2012DN04875A (de) * | 2009-12-08 | 2015-09-25 | Health Research Inc | |
| CN102776154A (zh) * | 2012-08-22 | 2012-11-14 | 天津三箭生物技术有限公司 | 小鼠抗人β-Tubulin单克隆抗体及分泌该单克隆抗体的杂交瘤细胞株 |
| CN103083684B (zh) * | 2012-12-03 | 2014-08-27 | 西南大学 | 一种提高肝片吸虫Cat L1（FhCat L1）DNA疫苗免疫保护率的方法 |
| CN103203028A (zh) * | 2012-12-03 | 2013-07-17 | 西南大学 | 一种提高抗肝片吸虫病dna疫苗免疫保护率的疫苗组合及制备方法 |
| WO2019145730A1 (en) * | 2018-01-25 | 2019-08-01 | Benchmark Animal Health Limited | Sea lice antigens and vaccines |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2045663A1 (en) * | 1989-01-31 | 1990-08-01 | Sonia Louise Crameri | Vaccine for the preventative treatment of infection of liver fluke in ruminants |
| US5610286A (en) * | 1991-11-04 | 1997-03-11 | The Regents Of The University Of California | DNA's encoding natural killer cell enhancing factor |
| CA2147378A1 (en) * | 1992-10-21 | 1994-04-28 | John P. Dalton | Vaccine containing a thiol protease |
| GB9312324D0 (en) * | 1993-06-15 | 1993-07-28 | Pitman Moore Inc | Vaccine |
| GB9419969D0 (en) * | 1994-10-04 | 1994-11-16 | Mallinckrodt Veterinary Inc | Vaccine |
-
1996
- 1996-06-11 GB GBGB9612214.8A patent/GB9612214D0/en active Pending
-
1997
- 1997-06-11 BR BR9710849-9A patent/BR9710849A/pt active Search and Examination
- 1997-06-11 AT AT97925196T patent/ATE361363T1/de not_active IP Right Cessation
- 1997-06-11 CA CA002256710A patent/CA2256710A1/en not_active Abandoned
- 1997-06-11 US US09/202,329 patent/US6676944B2/en not_active Expired - Fee Related
- 1997-06-11 CN CN97195427.5A patent/CN1221451A/zh active Pending
- 1997-06-11 WO PCT/GB1997/001573 patent/WO1997047740A2/en active IP Right Grant
- 1997-06-11 NZ NZ333265A patent/NZ333265A/xx unknown
- 1997-06-11 ES ES97925196T patent/ES2287954T3/es not_active Expired - Lifetime
- 1997-06-11 EP EP97925196A patent/EP0953047B1/de not_active Expired - Lifetime
- 1997-06-11 AU AU30424/97A patent/AU732807B2/en not_active Ceased
- 1997-06-11 DE DE69737691T patent/DE69737691T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE69737691T2 (de) | 2008-01-10 |
| AU732807B2 (en) | 2001-05-03 |
| CN1221451A (zh) | 1999-06-30 |
| US6676944B2 (en) | 2004-01-13 |
| ATE361363T1 (de) | 2007-05-15 |
| GB9612214D0 (en) | 1996-08-14 |
| ES2287954T3 (es) | 2007-12-16 |
| AU3042497A (en) | 1998-01-07 |
| WO1997047740A3 (en) | 1998-03-26 |
| US20030124137A1 (en) | 2003-07-03 |
| BR9710849A (pt) | 2000-01-11 |
| NZ333265A (en) | 2000-07-28 |
| EP0953047A2 (de) | 1999-11-03 |
| EP0953047B1 (de) | 2007-05-02 |
| CA2256710A1 (en) | 1997-12-18 |
| WO1997047740A2 (en) | 1997-12-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA199800946A1 (ru) | Концентрированный препарат антител | |
| EA199800563A1 (ru) | Антагонисты гормона, высвобождающего гонадотропин | |
| DE69737691D1 (de) | Impfstoff, der peroxiredoxin enthält | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| EA200300171A1 (ru) | Циклопентаноиндолы, композиции, содержащие данные соединения, и способы лечения | |
| EA200201214A1 (ru) | Замещенные тиоацетамиды | |
| ATE309378T1 (de) | Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung | |
| RS51157B (sr) | Baff receptor (bcma), imunoregulatorni agens | |
| DE60144145D1 (de) | Subtilisin-variante | |
| AR053946A2 (es) | Variante de alfa-amilasa de bacillus stearothermophilus original | |
| ES2196305T3 (es) | Composiciones que contienen moleculas inmunogenas y factor de estimulacion de colonias de granulocitos magrofagos como adyuvante. | |
| DK0799209T3 (da) | Sulfonamider | |
| EA200100509A1 (ru) | Модифицированные экзосомы и их применение | |
| EA199700253A1 (ru) | Производные нодулиспоровой кислоты | |
| CY1109207T1 (el) | Διαδικασια εχινοκανδινης | |
| DE69515340D1 (de) | Impfstoff gegen mycobakterielle infektionen | |
| ATE321534T1 (de) | Verbesserte liposomale formulierung | |
| ATE309264T1 (de) | Peptidyl-2-amino-1hydroxyalkansulfonsäuren als cystein-protease-inhibitoren | |
| AR013528A1 (es) | PROTEíNA-2 QUIMIOTÁCTICA MONOCíTICA (MCP-2) HUMANA AMINO TERMINALMENTE TRUNCADA, MOLÉCULA DE ADN QUE LA CODIFICA, VECTOR DE EXPRESIoN Y CÉLULA HUÉSPED CORRESPONDIENTES, PROCESO RECOMBINANTE PARA PREPARAR DICHAS PROTEíNAS, USO DE DICHAS PROTEíNAS PARA LA FABRICACIoN DE UN MEDICAMENTO uTIL PARA LA TER | |
| AR017887A1 (es) | Estructuras artificiales de acidos nucleicos, procedimiento para su preparacion, celula aislada y uso de dichas estructuras y dicha celula para lamanufactura de un medicamento | |
| ES2156642T3 (es) | Composicion que comprende un derivado de acido cinamico y un polimero poliaminado. | |
| AR002742A1 (es) | Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn | |
| AR007852A1 (es) | Una composicion de barra de jabon de base anionica que comprende tensioactivos anfoteros y/o zwitterionicos | |
| SE9904674D0 (sv) | Novel compounds | |
| AR026488A1 (es) | Composicion cosmetica de elevado comportamiento que comprende al menos un polimero filmogeno |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |